Home › Politics › China’s Hengrui posts 89% rise in third-quarter net...
Politics

China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates

China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates
Key Points

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating analyst estimates of 8.55 billion yuan amid stronger innovative drug sales. Net profit reached 2.46 billion yuan for the three months ended September 30, jumping 88.92 per cent year on year and exceeding the Bloomberg analyst consensus estimate of 2.38 billion yuan. Improving innovative drug sales and out-licensing revenue...

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating analyst estimates of 8.55 billion yuan amid stronger innovative drug sales. Net profit reached 2.46 billion yuan for the three months ended September 30, jumping 88.92 per cent year on year and exceeding the Bloomberg analyst consensus estimate of 2.38 billion yuan. Improving innovative drug sales and out-licensing revenue...
China (LOCATION) Hengrui (PERSON) Jiangsu Hengrui Pharmaceuticals (ORG) Bloomberg (ORG)
Originally published by South China Morning Post Read original →